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Abstract
The reconstruction of the external ear to correct congenital deformities or repair following trauma remains a significant
challenge in reconstructive surgery. Previously, we have developed a novel approach to create scaffold-free, tissue
engineering elastic cartilage constructs directly from a small population of donor cells. Although the developed constructs
appeared to adopt the structural appearance of native auricular cartilage, the constructs displayed limited expression and
poor localization of elastin. In the present study, the effect of growth factor supplementation (insulin, IGF-1, or TGF-b1) was
investigated to stimulate elastogenesis as well as to improve overall tissue formation. Using rabbit auricular chondrocytes,
bioreactor-cultivated constructs supplemented with either insulin or IGF-1 displayed increased deposition of cartilaginous
ECM, improved mechanical properties, and thicknesses comparable to native auricular cartilage after 4 weeks of growth.
Similarly, growth factor supplementation resulted in increased expression and improved localization of elastin, primarily
restricted within the cartilaginous region of the tissue construct. Additional studies were conducted to determine whether
scaffold-free engineered auricular cartilage constructs could be developed in the 3D shape of the external ear. Isolated
auricular chondrocytes were grown in rapid-prototyped tissue culture molds with additional insulin or IGF-1
supplementation during bioreactor cultivation. Using this approach, the developed tissue constructs were flexible and
had a 3D shape in very good agreement to the culture mold (average error ,400 mm). While scaffold-free, engineered
auricular cartilage constructs can be created with both the appropriate tissue structure and 3D shape of the external ear,
future studies will be aimed assessing potential changes in construct shape and properties after subcutaneous implantation.
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Introduction
Total or partial reconstruction of the external ear remains one
of the most difficult challenges in reconstructive surgery [1–4].
While there are a few approaches currently available (e.g. sculpted
autologous costal cartilage grafts, alloplastic implants), these
procedures carry significant morbidity, are prone to surgical
complications, and the natural shape of the ear can be difficult to
recreate [1,3,5]. To address these deficiencies, one promising
method for external ear reconstruction involves the use of
anatomically shaped, tissue engineered cartilage constructs.
Despite this potential, several technical hurdles need to be
overcome to develop functional constructs suitable for ear
reconstruction [2].
One of the major shortcomings of this approach is that the
native structure of auricular cartilage is not easily reproduced in
vitro. Auricular cartilage is an elastic cartilaginous tissue that
possesses with two discrete zones: (i) a central cartilaginous region
(or chondrium) and (ii) an outer fibrous region, termed the
perichondrium. The central, cartilaginous region is rich in
collagen II and large aggregating proteoglycans as well as
abundant elastic fibres (crosslinked elastin and associated micro-
fibrils) [6]. The central cartilaginous region is surrounded by the
perichondrium — a thin fibrous tissue layer believed to be
essential for the growth and maintenance of elastic cartilage
[1,7,8]. The perichondrium is rich in collagen type I fibres, small
non-aggregating proteoglycans and contains numerous fibroblas-
tic-like cells. Although various different types of biomaterial
scaffolds have been explored for auricular cartilage engineering
(e.g. polyglycolic acid (PGA), polycaprolactone (PCL), polylactic
acid (PLA)) [1,3], these scaffolds are primary aimed at recreating
the cartilaginous zone even though the need for the engineered
constructs to possess a functional perichondrium has long been
noted [7,9,10]. Relatively few studies have been able to address
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this shortcoming with neo-perichondrial formation typically only
observed after subcutaneous implantation [4,11,12]. While a
significant advance, this necessitates the need for a pre-implanta-
tion stage (e.g. abdominal) to functionalize the construct prior to
implantation at the defect site [4].
Recently, we have developed a novel approach to create large-
sized, engineered auricular cartilage constructs directly from a
very small population of donor cells (,13,000 cells/cm2) without a
separate cell expansion phase or scaffold [13]. The cells are
cultivated in a continuous flow bioreactor which elicits the
extensive growth of new cartilaginous tissue. The developed
constructs adopt the structural appearance of native auricular
cartilage with distinct cartilage and perichondrium regions [13] —
suggesting that the development of procedures with fewer clinical
stages can be achieved. However, elastin expression by auricular
chondrocytes in vitro can be problematic [7,14–16] with generally
reduced expression in the engineered constructs [17]. Growth
factor stimulation is a widely used method to improve tissue
formation as well as the expression of specific extracellular matrix
(ECM) macromolecules. In terms of elastogenesis, several studies
have demonstrated improved elastic fibre formation in different
cell types with supplementation of insulin, IGF-1, TGF-b1, or
CFGF [18–21]. Interestingly, a subset of these growth factors has
also been shown to elicit an anabolic response in cartilage;
specifically, insulin, IGF-1, and TGF-b1 [22,23]. As an attempt to
improve the quality of the engineered auricular cartilage
constructs, the purpose of this study was to investigate the
potential of insulin, IGF-1, and TGF-b1 stimulation during
bioreactor culture to improve the expression and localization of
elastic cartilaginous ECM proteins in the engineered constructs in
a similar fashion to native auricular cartilage.
Materials and Methods
Rabbit Auricular Chondrocyte Harvest and Isolation
This study was performed with approval from the University
Animal Care Committee (UACC) at Queen’s University. Full
thickness auricular cartilage was harvested from the ear of
adolescent female New Zealand white rabbits (,500 mg of
extracted tissue from 260.5 kg; ,12 weeks old animals) (Charles
River Laboratories, Wilmington, USA) to reflect the general age of
patients undergoing auricular reconstruction. Ears were complete-
ly dissected free of skin with the inner chondrogenic layer and the
outer perichondrial layer were kept entirely intact. The tissue was
cut in small fragments and digested with 0.5% protease (w/v)
(Sigma-Aldrich, Oakville, Canada) followed by 0.15% collagenase
A (w/v) (Roche Diagnostics Canada, Laval, QC) in Ham’s F12
media (Hyclone, Logan, USA) overnight at 37 uC with 95%
relative humidity and 5% CO2. Auricular chondorcytes were
isolated by centrifugation (7006g for 7 minutes) with the resultant
cell pellet washed 3 times with Ham’s F12 media. Viable cells,
determined by Trypan Blue dye (Sigma-Aldrich) exclusion [24]
were then seeded in low-density monolayers in a continuous flow
bioreactor. To minimize inter-animal variability, tissue was
obtained from several ears (up to 3 per experiment obtained from
different animals) and pooled together. Tissue constructs were
generated from two different batches of isolated cells (total of
N = 4–6 animal donors). Native tissue samples were harvested
from the same animals and were used for testing (histological,
immunohistochemical, biochemical, and mechanical) immediately
after harvest.
Continuous Flow Bioreactor
A continuous flow bioreactor system was used to maintain a
constant supply of fresh medium to the developing construct in a
low fluid shear environment [25,26]. Briefly, the reactor consisted
of multichannel vented polypropylene chambers to house single
constructs (3 cm2 containing a maximum media volume of 4 mL).
A constant 10 mL/min flow of fresh media (from aerated
reservoirs) was provided by a peristaltic pump (Ismatec, Cole
Parmer Canada, Anjou, Canada) with waste media collected in a
vented reservoir (resulting in an average residence time of
6.67 hours). The bioreactor was housed in an incubator main-
tained at 37uC with 95% relative humidity and 5% CO2.
Hormone and Growth Factor Supplementation
To determine the most effective stimulatory factors to improve
the accumulation of specific tissue constituents in the engineered
elastic cartilage constructs, three different hormone/growth factors
were investigated: 10 nM IGF-1 (Peprotech, Rocky Hill, NJ,
USA), 100 nM Insulin (Sigma, St Louis, MO, USA), or 0.1 nM
TGF- b1 (Peprotech, Rocky Hill,NJ, USA). The selected
concentrations were based on the mid-range concentrations used
in previous studies [18–21]. Isolated cells were seeded in low-
density monolayers (13,000 cells/cm2 or 40,000 cells/well) directly
on the bottom surface of the reactor wells in Ham’s F12 media
(Hyclone, Logan, USA) supplemented with 20 mM HEPES (4-
2(2-hydroxyethyl) piperazine-1-ethanesulfonic acid) (Sigma-Al-
drich), 14 mM sodium bicarbonate (NaHCO3), 100 mg/mL
ascorbate, 20% FBS, and an antibiotic solution containing:
100 U/mL penicillin, 100 mg/mL streptomycin and 0.25 mg/mL
amphotericin B (Sigma-Aldrich) in the presence, or absence, or
additional hormone/growth factors (IGF-1, insulin or TGF- b1).
After seeding, all preparations were maintained under no-flow
conditions for 48 hours. Preparations were then cultured under a
constant media flow rate of 10 mL/min for a period of 4 weeks.
Media reservoirs were changed every 2–3 days and supplemented
with fresh hormone/growth factors, ascorbic acid and antibiotics.
After the 4 week culture period, developed constructs were
harvested, weighed (wet weight). Constructs were tested mechan-
ically and then divided into three parts and processed for
histological/immunohistochemical evaluation, biochemical analy-
ses and transmission electron microscopy, respectively.
Assessment of Tissue Thickness and Mechanical
Properties
The thickness of the tissue constructs was determined using a
needle probe method [27] in conjunction with a Mach-1
Micromechanical Testing system (Biomomentum, Laval, QC,
Canada) equipped with a 1 kg load cell (0.05 g resolution)
averaged over three random locations in the construct. The
thickness of native tissue samples was measured using calipers
(0.5 mm resolution). Mechanical testing of native auricular
cartilage and engineered cartilage constructs was then performed
using a Mach-1 Micromechanical Testing system (Biomomentum,
Laval, QC, Canada) equipped with a 1 kg load cell. Tissue
mechanical properties (elastic modulus and Poisson’s ratio at 37uC
in Ham’s F12 media) was determined using a double compressive
indentation method [25,28,29] using two plane-ended indentors (2
and 6 mm diameter). Compressive indentations were conducted at
a ramp rate of 10% strain/s to a maximum of 10% strain. Samples
were then allowed to equilibrate in media for approximately 20
minutes between indentations. The resulting force-deformation
response from both indentations (collected a frequency of 10 Hz)
were then used to determine the elastic modulus and Poisson’s
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ratio of the tissue sample using custom-designed code based on the
theoretical model of cartilage indentation [28,29].
Histological Evaluation
Engineered constructs as well as native auricular cartilage tissue
samples were fixed in 4% paraformaldehyde (in 0.1 M PBS,
pH 7.2) for 24 hours, dehydrated in graded ethanol solutions and
embedded in paraffin at 65uC. Thin (5 mm thick) sections were cut
and mounted on Superfrost slides (Fisher Scientific, Mississauga,
Canada) and dried for 24 hours at 37uC. Sections were stained
with safranin-O (proteoglycan stain), Weigert’s resorcin-fuchsin
(elastin/elastic fiber stain) or hematoxylin & eosin (H&E; general
connective tissue stain). Stained sections were examined by light
microscopy using a Zeiss Axio-Image M1 microscope (Go¨ttingen,
Germany).
Immunochemical Localization of Collagen Types and
Elastin
Immunohistochemical localization of collagen types I and II in
the engineered constructs and native auricular cartilage tissues
samples was performed as previously described [21,25]. Briefly,
after deparaffinization and dehydration, sections were enzymati-
cally treated with 0.05% of trypsin (pH 7.8) for 30 minutes at 37uC
to facilitate antibody binding. Endogenous peroxidase activity was
blocked with 1% H2O2 and 1% BSA (in PBS) for 30 minutes.
Sections were then incubated with mouse monoclonal antibodies
against collagen type I (ab90395 1:100; USA) or collagen type II
(II-II6B3 at 187 mg/mL; Developmental Studies Hybridoma
Bank, Iowa, USA) all diluted in 1% BSA (in PBS, pH 7.4)
overnight at 4uC. Following primary antibody incubation, sections
were rinsed in PBS (pH 7.4), and incubated with biotinylated anti-
mouse secondary antibodies (Vector Laboratories Inc., Burlin-
game, USA) using the Vectastain Elite ABC kit (Vector
Laboratories) for 2 hours at room temperature, followed by
incubation with diaminobenzidine (DAB) for 6 minutes at room
temperature. The sections were counter-stained with Harris’
hematoxylin and mounted in permanent mounting medium.
Stained sections were examined by light microscopy using a Zeiss
Axio-Image M1 microscope (Go¨ttingen, Germany).
Immunofluorescence localization of elastin and collagen X in
the engineered constructs and native auricular cartilage tissues
samples was also performed as previously described [21,25].
Briefly, after deparaffinization and dehydration, sections were
enzymatically treated with 0.25 units/mL chondroitinase ABC
(Sigma-Aldrich) in tris-acetate buffer (40 mM tris acetate with
1 mM EDTA, pH 8.5) for 1 hour at 37uC followed by 0.25 units/
mL keratinase (Sigma-Aldrich) tris-acetate buffer for 30 minutes at
37uC to facilitate antibody binding. To reduce non-specific protein
binding, the sections were blocked with 1% BSA (in PBS) for 30
minutes at room temperature. Sections were then incubated with
mouse monoclonal antibodies against elastin (BA4 at 1:100
dilution; Abcam, Cambridge, USA) or with rabbit polyclonal
antibodies against collagen type X (ab58632 at 1:150 dilution;
Abcam) all diluted in 1% BSA (in PBS, pH 7.4) overnight at 4uC.
Following primary antibody incubation, sections were rinsed in
PBS (pH 7.4), and incubated with Texas Red (elastin) or FITC
(collagen X) labeled anti-mouse or anti-rabbit secondary antibod-
ies (1:200 dilution; Abcam) for 2 hours at room temperature.
Sections were counterstained and mounted with DAPI (Vector
Laboratories) and examined by fluorescent microscopy using a
Zeiss Axio-Image M1 microscope with Axiovision software (Carl
Zeiss, Oberkochen, Germany).
For all immunohistochemical studies, non-specific staining was
assessed by replacement of the primary antibody with non-
immune serum. These experiments were completed at least three
times with no positive staining detected in the negative controls.
Transmission Electron Microscopy (TEM)
Engineered constructs and native auricular cartilage tissue
samples were fixed in a Karnovsky solution for 2 hours at room
temperature. Samples were then post-fixed in 1% osmium
tetroxide for 1 hour at 4uC, dehydrated in graded ethanol
solutions, and embedded in epoxy resin Epon 812 (Electron
Microscope Science, Hatfield, PA). Ultrathin sections (70 nm)
were cut and collected on copper grids, stained with uranyl acetate
and lead citrate and examined using a LEO 906 transmission
electron microscope (LEO Elektronenmikroskopie GmbH, Ober-
kochen, Germany).
Biochemical Quantification of Matrix Constituents
Engineered construct samples were weighed again to determine
the percentage sample mass of the entire developed construct. The
dry weight of the engineered construct as well as native auricular
cartilage tissues samples was then determined after overnight
lyophilization. Samples were then digested by papain (bioreactor
samples: 40 mg/mL; native tissue samples: 80 mg/mL in 20 mM
ammonium acetate, 1 mM EDTA and 2 mM dithiothreitol) for
72 hours at 65uC and stored at 220uC until analysis. Aliquots of
the digest were assayed separately for DNA, proteoglycan and
collagen content. The DNA assay was estimated using Hoechst
33258 dye (Sigma-Aldrich) [30]. The proteoglycan content was
estimated by quantifying the amount of sulphated glycosamino-
glycans using 1,9-dimethylmethylene blue (DMMB) dye binding
assay (Sigma-Aldrich) [31,32] Total collagen content was deter-
mined by the determination of hydroxiproline content. Briefly,
aliquots of the papain digest were hydrolyzed in 6 N HCl for
18 hours at 110uC and the hydroxyproline content was deter-
mined in the hydrolyzate using chloramine-T/Ehrlich’s reagent
assay [33]. Total collagen content was estimated assuming
hydroxyproline accounts for 10% of the total collagen mass in
cartilage [34].
Creation of Ear Mold Constructs
To explore the possibility of creating elastic cartilaginous
constructs in the shape of the external ear, rapid-prototyped tissue
culture molds were created from a previously generated 3D
polygonal external ear model developed from CT imaging
(TurboSquid, New Orleans, LA). Surface geometry of the external
ear was extracted from the 3D model (1/2 size model; 27 mm in
length measured from helix to lobe) and incorporated into a
cylindrical mold (sized to fit within the reactor well) fabricated out
of non-cytotoxic, acrylonitrile butadiene styrene (ABS) thermo-
plastic by rapid-prototyping (Dimension sst 1200es, Stratasys,
Eden Prairie, USA). Mold surfaces were first coated with chicken
type II collagen (Sigma-Alrich) [25] and then directly seeded with
,20,000 isolated chondrocytes (13,000 cells/cm2) and maintained
under no-flow conditions for 48 hours. Mold cultures were grown
under a constant media flow (10 mL/min) for 4 weeks with either
additional IGF-1 or insulin, as described previously. Previous work
has demonstrated no adverse effects of the mold material or
collagen coating on the developed cartilaginous tissues [25]. After
harvest, the surface morphology of both the construct and mold
were measured by 3D laser scanning (SG2 Series, ShapeGrabber,
Ottawa, Canada) with a resolution of 100 mm. Prior to laser
scanning, the anatomically-shaped constructs were first coated
with hair-spray to create a reflective surface and avoid potential
issues with excess moisture on the construct surface. Shape fidelity
of the engineered defect-specific construct was evaluated by
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determining the root-mean-square (RMS) error between the mold
and construct surfaces using an iterative closest point matching
algorithm [35].
Statistical Analyses
Two separate batches of cells were used to create the engineered
constructs (N = 4–6 animal donors in total) and the results of the
replicate samples were pooled together prior to conducting the
statistical analyses (total n = 5–8 samples/group). Due to the
relatively small number of replicate samples generated from each
animal, the potential effect of animal donor was not included in
the statistical models. All results were expressed as the mean 6
standard error of the mean (SEM). Biochemical quantification
data was analyzed using a one-way ANOVA and Tukey’s post-hoc
testing. Data was checked prior to performing statistical tests for
both normality and equal-variance. Statistical tests were conduct-
ed using statistical software (SPSS version 16, SPSS Inc., Chicago,
USA) and significance was associated with p-values less than 0.05.
Results
Structure of Engineered Elastic Cartilage Constructs
Elastic cartilaginous cartilage constructs were generated from a
small population of isolated cells and long-term bioreactor culture
(4 weeks) using media supplemented with anabolic factors (IGF-1,
insulin or TGF-b1) to improve overall tissue growth and to better
localize extracellular (ECM) macromolecules within the developed
tissue constructs. While each group resulted in the formation of
large tissue constructs (,3 cm2), cells grown in the presence of
TGF-b1 did not appear to form good quality tissue constructs and
were very fragile (Figure 1). Alternatively, cells grown in the
presence of IGF-1 or insulin were able to form tissue constructs
that were glistening white in color, firm in consistency, and easily
handled. These tissue constructs were also visually thicker than the
constructs grown in the presence of TGF-b1 or controls (without
growth factor stimulation).
Histological evaluation of the engineered constructs also
revealed that both IGF-1 and insulin supplemented media resulted
in the formation of neotissues with greater similarities to native
auricular cartilage (Figure 2). While the tissue constructs (controls,
IGF-1 and insulin) displayed distinct cartilaginous and perichon-
drial-like regions, these regions were more defined and better
organized as a result of IGF-1 (Figure 2C, G, K, O) or insulin
(Figure 2D, H, L, P) supplementation. Within the cartilaginous
region, control cultures (without growth factor supplementation)
positively stained for sulphated proteoglycans (safranin-O) (Fig-
ure 2B) and elastin (resorcin-fuchsin) (Figure 2F) with round and
oval shaped chondrocytes and some binucleated cells. IGF-1 and
insulin treated cultures displayed more intense staining for both
sulphated proteoglycans (Figure 2C, D respectively) and elastin
(Figure 2G, H respectively) with enlarged binucleated cells with
elongated morphologies more similar to native cartilage (Fig-
ure 2A, B respectively). The developed perichondrial-like region
was similar amongst the groups, which did not stain for sulphated
proteoglycans (Figure 2A) and contained smaller cells similar to
fibroblasts. In contrast, TGF-b1 supplemented cultures appeared
to resemble poorly organized tissue without the presence of
hypertrophic cells or a distinct perichondium-like region (Figure
S1). For this reason, further immunohistochemical assessment on
the TGF-b1 cultures were not undertaken.
Figure 1. Macroscopic appearance of generated scaffold-free, engineered tissue constructs. Macroscopic appearance of the tissue
generated from the monolayer cell preparations after 4 weeks of bioreactor culture. (A) Control, (B) IGF-1, (C) Insulin, and (D) TGF-b1. Scale bar: 1 cm.
doi:10.1371/journal.pone.0105170.g001
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Immunohistochemical assessment showed that collagen I was
primarily located in the perichondium-like region within the
developed constructs (controls, IGF-1 and insulin) (Figure 2J–L);
however, the insulin supplemented cultures displayed few cells
with intracellular staining for collagen I (Figure 2L) in the
cartilaginous region. The cartilaginous regions stained positive
for both collagen II (Figure 2N–P) and collagen X (Figure 3D, F,
H) in all of the developed constructs. Collagen X staining
appeared to be more intense in the insulin supplemented cultures
(Figure 3H) compared to the cultures supplemented with IGF-1
(Figure 3F) or the control cultures (Figure 3D) (no growth factor
supplementation). However, in each of these constructs, sparse
staining for collagen X staining was also detected in the
perichondrial-like region. The presence of elastin was observed
in the engineered constructs, which was also affected by growth
factor supplementation (Figure 3C, E, G). Without growth factor
supplementation (controls), elastin was primarily observed intra-
cellularly and was present in both the cartilaginous and
perichondrial-like regions (Figure 3C). However, supplementation
with either IGF-1 (Figure 3E) or insulin (Figure 3G) appear to be
better localize elastin expression in the cartilaginous region, with a
greater effect observed in response to insulin supplementation.
Alternatively, in response to IGF-1 supplementation, elastin
expression was observed both intracellularly and in the developed
ECM (Figure 3E).
Tissue Ultrastructure
Transmission electron microscopy (TEM) evaluation of tissue
ultrastructure showed that the cells within the engineered tissue
constructs resembled chondrocytes and the developed tissue
appeared to display all of the characteristics of native auricular
cartilage (cytoskeleton, lipid droplets, defined territorial and
interterritorial matrices) (Figure 4). Extracellular elastin, observed
as electron-dense amorphous aggregates, was also detected in all of
the engineered constructs (Figure 4D, F, H). The control cultures
(Figure 4D) (no growth factor supplementation) displayed sparse
and thin elastic fibres, which were increased in response to both
IGF-1 (Figure 4F) and insulin (Figure 4H) supplementation.
Similar to the immunohistochemical results, the most prominent
and thickest elastic fibres were detected in the ECM of the IGF-1
supplemented cultures (Figure 4F). However, compared to native
auricular cartilage (Figure 4B), the elastic fibres in the engineered
tissues appeared to be less dense and organized.
Physical and Biochemical Properties of Accumulated
Extracellular Matrix
Growth factor supplementation also had an observable effect on
biochemical and physical properties of the engineered elastic tissue
constructs in terms of tissue cellularity, ECM accumulation,
thickness, and resultant mechanical properties. Although no
statistical differences were observed between IGF-1 and insulin
supplementation, these cultures had significantly higher DNA (83–
93% increase, p,0.01), proteoglycan (3.2–3.3 fold increase, p,
0.01), and collagen (2.1–2.5 fold increase, p,0.01) contents
Figure 2. Histological and immunohistochemical appearance of generated scaffold-free, engineered tissue constructs. Histological
and immunohistochemical appearance of the tissue generated from the monolayer cell preparations after 4 weeks of bioreactor culture compared to
native auricular cartilage. Native auricular cartilage (A, E, I, and M), Control (B, F, J, N), IGF-1 (C, G, K, O), and Insulin (D, H, L, P). Safranin-O (sulphated
proteoglycan stain) (A, B, C, D), Resorcin-Fucsin (elastin stain) (E, F, G, H), Collagen I (I, J, K, L), and Collagen II (M, N, O, P). Letters ‘‘P’’ and ‘‘C’’ refer to
the perichondrial-like and cartilaginous regions, respectively. Scale bar: 30 mm.
doi:10.1371/journal.pone.0105170.g002
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Figure 3. Immunohistochemical localization of elastin and collagen X in the scaffold-free, engineered tissue constructs.
Immunohistochemical localization of elastin (red) (A, C, E, G) and collagen X (green) (B, D, F, H) in the engineered elastic cartilaginous constructs
generated from monolayer preparations after 4 weeks of bioreactor culture compared to native auricular cartilage. Native auricular cartilage (A, B),
Control (C, D), IGF-1 (E, F), and Insulin (G, H). Letters ‘‘P’’ and ‘‘C’’ refer to the perichondrial-like and cartilaginous regions, respectively. Scale bar:
30 mm.
doi:10.1371/journal.pone.0105170.g003
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compared to the controls (no growth factor supplementation)
(Table 1). Similarly, construct mass (wet and dry weights) were
also significantly higher in the IGF-1 and insulin supplemented
cultures (1.9–2.3 fold increase, p,0.01) without corresponding
changes in water content (Table 1). When normalized to tissue
weight or cellularity, generally similar effects of IGF-1 and insulin
supplementation were observed, with the exception of tissue
cellularity, which was similar amongst all of the cultures (Table 2).
However, when compared to native auricular cartilage, collagen
accumulation and cellularity were lower (p,0.05) in the
engineered constructs. Proteoglycan accumulation approached
the values of native cartilage without growth factor supplemen-
tation (controls), whereas was higher (p,0.05) in the constructs
stimulated by wither IGF-1 or insulin (Table 2). Similar to the
previous results, supplementation with TGF-b1 resulted in the
generation of constructs with significantly less ECM and lower
cellularity compared to all of the other developed constructs
(controls, IGF-1 or insulin) (Tables 1 and 2).
The thickness of the cultures was significantly increased with
IGF-1 and insulin supplementation (2.8-fold increase, p,0.01) and
were similar to that of native auricular cartilage (Table 3). While
the elastic modulus of the constructs was improved by growth
factor supplementation (54–69% increase, p= 0.07), the engi-
neered constructs displayed lower moduli when compared to
native auricular cartilage (Table 3). However, the IGF-1 and
insulin supplemented constructs appeared to possess a similar
Poisson’s ration to that of native cartilage (Table 3). Note that as
the TGF-b1 constructs were too fragile, it was not possible to
reliably determine tissue thickness or mechanical properties.
Development of Anatomically Shaped, Scaffold-Free
Auricular Cartilage Constructs
Due to the promising effects of IGF-1 and insulin supplemen-
tation of the developed elastic cartilaginous tissue constructs,
isolated cells were seeded in rapid-prototyped tissue culture molds
in the shape of the external ear. After 4 weeks of the bioreactor
culture, resultant tissue constructs could be easily removed from
the mold, were flexible and appeared to retain their 3D shape
(Figure 5). 3D laser scanning of the construct and rapid-
prototyped molds were then conducted to assess the shape fidelity.
Construct shape fidelity appeared to be preserved with very good
agreement between the mold and engineered construct. The
average positional error (RMS) between the construct and
corresponding mold surfaces were 368620 mm (IGF-1, n = 4)
and 391636 mm (insulin, n = 4), with the majority of the construct
surface within 100 mm (lower than the resolution of the 3D
scanner) of the mold and higher deviation noted primarily at
regions of high curvature (Figure 5).
Discussion
Sculpted autologous costal cartilage grafts for the reconstruction
of the external ear have good long-term durability [36–38] as well
as the potential to grow with the patient [1,3]. First introduced by
Tanzer [38], this multi-stage procedure (e.g. 4-stage Brent
procedure [36] or 2-stage Nagata procedure [37]) is recognized
as surgically demanding and involves harvesting of a large amount
of autologous donor cartilage for subsequent shaping. This can
result in significant donor-site morbidity and patients must have a
sufficient supply of donor cartilage to be candidates — potentially
delaying the age at which the reconstruction can be performed
[1,3]. To address this concern, we have developed an approach to
generate scaffold-free engineered auricular cartilage constructs
directly from a small amount of isolated cells [13] without the need
for additional cell expansion. Although the bioreactor cultivated
constructs appeared to adopt the structural appearance of native
auricular cartilage, the constructs displayed limited expression and
poor localization of elastin (a fundamental constituent of the elastic
cartilage matrix). In the present study, the effect of growth factor
supplementation (insulin, IGF-1, or TGF-b1) was investigated to
stimulate elastogenesis as well as to improve overall tissue
formation. While previous studies have shown that these factors
can upregulate elastin expression [18–21], stimulation with TGF-
b1 did not elicit positive effects on tissue formation in bioreactor
culture. This result may be due to the observed differences
between transient as opposed to continuous exposure to growth
Figure 4. Transmission microscopy of cellular ultrastructural and extracellular matrix organization. Transmission electron micrographs,
within the cartilaginous region, of the engineered elastic cartilaginous constructs after 4 weeks of bioreactor culture compared to native auricular
cartilage. Native auricular cartilage (A, B), Control (C, D), IGF-1 (E, F), and Insulin (G, H). Separate images were taken for both the cellular ultrastructure
(A, C, E, G) and organization of the extracellular matrix (B, D, F, H). Arrows denote presence of elastic fibres. In native auricular cartilage, the elastic
fibres (B and insert) appear to be more organized, dense and weakly contrasted compared to the elastic fibres present in the engineered constructs
(D, F, H). Scale bars: A, C, E, G: 5 mm; B: 2 mm; D, F, H: 1 mm.
doi:10.1371/journal.pone.0105170.g004
Table 1. Biochemical properties of scaffold-free, engineered tissues.
Control TGF-b1 [0.1 nM] IGF-1 [10 nM] Insulin [100 nM]
(n=7) (n =5) (n =8) (n =8)
Total DNA (mg/construct) 3064a 4.460.4a 5866 5566
Total PG (mg/construct) 19186374a 95642a 62586880 635661071
Total Collagen (mg/construct) 23456903a 5046137a 577761780 493861562
Wet Weight (mg) 87613a 2365a 197620 183614
Dry Weight (mg) 961a 1.960.4a 1761 18.260.8
Water Content (%) 89.660.5 91.960.4 91.160.2 90.660.2
Biochemical Properties of Engineered Elastic Cartilaginous Tissues. Data presented as mean 6SEM.
PG: Proteoglycans.
aSignificantly different from all other groups (p,0.01).
doi:10.1371/journal.pone.0105170.t001
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factors in culture. Ng et al. [39] demonstrated that transient
exposure (14 of 42 days) of articular chondrocytes to TGF-b1 or
TGF-b3 resulted in improved cartilaginous tissue formation and
mechanical properties as opposed to continuous exposure for the
same period of time. Similarly, Are´valo-Silva et al. [40] observed
that 3 weeks of continuous exposure of auricular chondrocytes to
TGF-b1 also resulted in poor quality tissue formation. These
effects have been attributed to the temporal regulation of growth
factors (including TGF-b1) in vivo during both cartilage develop-
ment and wound healing [41,42].
In contrast to the effects of TGF-b1, a significant improvement
in growth and properties of the engineered elastic cartilage
constructs were observed in response to supplementation with
either insulin or IGF-1. Engineered constructs grown in the
presence of insulin or IGF-1 displayed thicknesses approaching
native auricular cartilage with improved deposition of cartilagi-
nous ECM and resultant mechanical properties. IGF-1 has long
been established as a potent anabolic factor used to improve the
formation of engineered cartilage, with several studies showing
increased deposition of cartilaginous ECM and improved
mechanical properties of the developed constructs [22,23,43].
Similarly, while insulin-transferrin-selenium (ITS) supplemented
media has also been shown to improve cartilage tissue formation
in vitro [44,45], recent work has shown that insulin alone is most
likely responsible for these effects [46,47]. Insulin and IGF-1
belong to the same peptide family and the similarity between their
molecular structures is probably responsible to similar effects
observed [48]. This is in agreement with our findings showing
increased elastin expression (by IHC) and better elastic fibre
formation (by TEM) in response to long-term stimulation by either
peptide. Potentially attributable to the concentrations used,
supplementation with IGF-1 resulted in apparently more mature
elastic fibre organization compared to supplementation with
insulin. Interestingly, supplementation with insulin or IGF-1 also
served to better localize elastin expression within the cartilaginous
region of the developed constructs. While all of the developed
constructs possessed distinct perichondrial and cartilaginous
regions (with the exception of constructs supplemented with
TGF-b1), control constructs (no growth factor supplementation)
expressed elastin (primarily intracellularly) in both the cartilagi-
nous and perichondrial-like regions. However, when grown in the
presence of insulin or IGF-1, elastin expression in the perichon-
drial-like region was reduced (insulin) or virtually undetected (IGF-
1), similar to the absence of elastin expression within perichon-
drium of native auricular cartilage. While the underlying
mechanisms responsible for this effect are currently unknown,
previous studies suggest that the response of perichondrial cells to
exogenous insulin and IGF-1 may be highly regulated. During
development, perichondrial cells (compared to chondrocytes)
express a higher proportion of IGF receptors (IGF-1R) [49,50]
and IGF binding proteins (IGFBP-4, IGFBP-5) [50]. The
perichondrium also contains a population of chondrogenic
progenitors (chondroblasts) [51,52], which have been shown to
differentiate into chondrocytes in response to exogenous IGF-1
[52]. Lastly, the expression of collagen X was also significantly
enhanced in response to stimulation by these peptides. Collagen X
is known as a marker of chondrocyte hypertrophy and mineral-
izing cartilages [6,53], but is also expressed in non-mineralizing
tissues, including auricular and nasoseptal cartilages [6]. Previous
studies have shown that IGF-1 can promote chondrocyte
hypertrophy [54,55] and our results suggest that insulin potentially
has a similar effect as the changes in collagen X expression and
cellular morphology were quite similar in response to either insulin
or IGF-1 supplementation.
Table 2. Biochemical properties of scaffold-free, engineered tissues compared to native auricular cartilage.
Control TGF-b1 [0.1 nM] IGF-1 [10 nM] Insulin [100 nM] Native Tissue
(n =7) (n =5) (n=8) (n =8) (n =6)
DNA [mg/mg dry wt.] 3.460.3 2.760.5 3.360.1 3.160.1 2.360.2a
PG [mg/mg dry wt.] 219639 44613a 362634 359640 231626
Collagen [mg/mg dry wt.] 163628 263617 332687b 264673 496635a
PG/DNA [mg/mg] 70618a 2068a 111612 114611 133614
Collagen/DNA [mg/mg] 68623 110623 101627 80622 230630a
Collagen/PG [mg/mg] 1.160.2 762a 0.860.1 0.660.1a 2.260.2a
Biochemical properties of engineered elastic cartilaginous tissue and native auricular tissue normalized to dry weight or DNA content. Data presented as mean 6SEM.
PG: Proteoglycans.
aSignificantly different from all other groups (p,0.05).
bSignificantly different from control (p,0.05).
doi:10.1371/journal.pone.0105170.t002
Table 3. Physical properties of properties of scaffold-free, engineered tissues.
Control IGF-1 [10 nM] Insulin [100 nM] Native Tissue
Thickness [mm] 168617a 463650 470652 506618
Elastic Modulus [kPa] 1364 2262b 2062b 100619a
Poisson’s Ratio 0.3160. 01 0.2960.01 0.2960.01 0.2860.02
Thickness and mechanical properties of engineered elastic cartilaginous tissues. Data presented as mean 6SEM; n=7–8/group.
aSignificantly different from all other groups (p,0.01).
bTrend from control (p= 0.07).
doi:10.1371/journal.pone.0105170.t003
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To determine whether anatomically shaped scaffold-free
auricular cartilage constructs could be developed, isolated cell
were grown in rapid prototyped culture molds. Resultant tissue
constructs had good agreement with the original cell culture mold
(average RMS error between construct and mold of less than
400 mm). This result was similar to our previous work in
generating shaped scaffold-free articular cartilage constructs that
could be matched to the defect site [25]. However, using this
approach, stronger shape correlations between the construct and
original mold were observed with articular chondrocytes (,
120 mm average positional error). While this effect may be due to
the differences in cell types, the external ear has a more complex
shape compared to the curvature(s) of cartilage within the knee.
On this note, the recreation of predominant over-hanging features
of the auricular (e.g. crus of the helix, tragus, and anti-tragus) for
certain individuals might prove to be challenging and may require
a modular mold to ensure accurate 3D shaping of the developed
constructs. Numerous studies have also demonstrated that
engineered auricular cartilage constructs can be developed in the
shape of the external ear with generally good spatial agreement to
the desired 3D shape [1,3,11,12,56,57]. However, shape fidelity in
auricular cartilage tissue engineering is a concern as prior studies
have shown that the engineered scaffolds can be susceptible to
significant shrinkage and/or shape distortions after subcutaneous
implantation [58]. Thus, while our initial results appear promising,
the next steps are to further characterize the anatomically-shaped
constructs (mechanically, histologically, biochemically) and then
determine whether these scaffold-free constructs can maintain
their 3D shape after implantation.
In this study, we have investigated the potential of growth factor
stimulation during bioreactor culture to improve expression and
localization of cartilaginous ECM proteins in scaffold-free
auricular cartilage constructs. Media supplementation with either
insulin or IGF-1 was successful at improving overall tissue growth
and properties with the developed constructs obtaining the
thickness native auricular cartilage. Insulin and IGF-1 also served
to upregulate elastogenesis and better localize elastin expression to
the cartilaginous regions of the developed constructs in a similar
fashion to native cartilage. In contrast, supplementation with
TGF-b1 had appeared to have a negative effect on tissue
formation and resultant constructs were generally thin and fragile.
These results also suggest that there may be some added benefit to
the use of a combination of insulin and IGF-1 on the formation
and properties of engineered auricular cartilage constructs. In
addition, other combinations of growth (including TGF-b1) should
also be investigated, as previous work has shown that the
combined effect of insulin and TGF-b1 serves to upregulate
elastic fibre formation in smooth muscles cell seeded fibrin
constructs [20]. Scaffold-free auricular cartilage constructs could
also be formed in the shape of the external ear using rapid
prototyped 3D culture molds. Although very good spatial
agreement between the developed construct and mold was
achieved, future studies will be aimed assessing potential changes
in construct shape and properties after subcutaneous implantation
and translation to the development of engineered human auricular
cartilage constructs.
Supporting Information
Figure S1 Histological appearance engineered tissue
constructs supplemented with TGF-b1. Histological ap-
pearance of the tissue generated from the monolayer cell
preparations after 4 weeks of bioreactor culture supplemented
with TGF-b1 stained with hematoxylin & eosin (H&E; general
connective tissue stain). Note that supplementation with TGF-b1
resulted in tissue constructs were poorly organized without the
presence of hypertrophic cells or a distinct perichondium-like
region. Scale bar: 30 mm.
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